Zydus Lifesciences Buyback Record Date is 23 February 2024.
The company was initially incorporated as Cadila Healthcare Private Limited on 15 May 1995, under the provisions of the Companies Act, 1956. It later converted to a public limited company and changed its name to Cadila Healthcare Limited on 17 July 1996. Subsequently, on 24 February 2022, the company changed its name to its present name, ‘Zydus Lifesciences Limited’.
Zydus Lifesciences is a prominent innovation-driven life sciences company in India. It operates across the pharmaceutical value chain, engaging in research and development, manufacturing, marketing, and selling of finished dosage human formulations. These include generics, branded generics, and specialty formulations, encompassing biosimilars and vaccines.
The company operates 35 manufacturing facilities, plants, and factories in India. Additionally, it maintains 7 research and development centers in the country, focusing on generic formulations, active pharmaceutical ingredients (API), vaccines, biologics, and new chemical entities across various dosage forms.
Zydus Lifesciences Buyback Record Date, Other Details
| Zydus Lifesciences Buyback Dates | 29 Feb – 6 Mar 2024 |
| Zydus Lifesciences Buyback Price | INR 1,005 per share |
| Market Price on Buyback Approval | INR 801.85 per share |
| Buyback Premium on Market Price | 25.34% |
| Buyback Offer Size (Shares) | 5,970,149 shares |
| Buyback Offer Size (Amount) | INR 600 crore |
| Offer Type | Tender |
| Promoter Participation | Yes |
| Face Value | INR 1 per share |
| Listing At | BSE, NSE |
Zydus Lifesciences Buyback Dates (Timeline)
| Board Meeting Intimation for Buyback Proposal | 29 January 2024 |
| Buyback Approval Date | 9 February 2024 |
| Public Announcement of Buyback | 13 February 2024 |
| Zydus Lifesciences Buyback Record Date | 23 February 2024 |
| Buyback Opening Date | 29 February 2024 |
| Buyback Closing Date | 6 March 2024 |
| Cut-off Date to receive completed tender forms by Registrar | 6 March 2024 |
| Verification Date by the Registrar | 12 March 2024 |
| Return of unaccepted shares by Registrar | 14 March 2024 |
| Extinguishment of accepted shares | 26 March 2024 |
Zydus Lifesciences Buyback 2024 Documents
Letter of Offer
Public Announcement
Board Approval
Upcoming Share Buyback
Zydus Lifesciences Buyback Entitlement Ratio
| Shareholder Category | Entitlement Ratio | Entitlement Ratio (in %) |
| Small Shareholders (less than INR 2 Lakh on record date) | 6/67 | 8.96 |
| General category (for all other Eligible Shareholders) | 2/395 | 0.51 |
A small Shareholder is defined as a shareholder who holds shares worth less than INR 2,00,000 as of the record date.
Zydus Lifesciences Financial Performance
| FY 2021 | FY 2022 | FY 2023 | |
| Revenue | 14,403.5 | 15,109.9 | 17,237.4 |
| Total Expenses | 11,844.8 | 12,609.2 | 14,230.1 |
| Net income | 2,185.0 | 4,618.3 | 2,091.9 |
Calculation of Investment in Buyback
| Maximum market value of a share holder as on record date | INR 2,00,000 |
| Buyback price per share | INR 1,005 |
| Maximum shares for small shareholders (2,00,000/1,005) | 200 shares * |
| Closing price of stock as of 9 February 2024 | INR 801.85** |
| Maximum amount invested in buyback (INR 801.85 x 200 shares) | INR 1,60,385 |
** For simplicity, we have considered the price on the buyback approval date
Zydus Lifesciences Buyback Acceptance Ratio
| Shares Tendered | Buyback Entitlement | Acceptance ratio | Buyback Profit | Profit in % |
| 200 | 18 | 18 (100%) | 3,656.7 | 2.28 |
| 200 | 18 | 36 (200%) | 7,313.4 | 4.56 |
| 200 | 18 | 54 (300%) | 10,970.1 | 6.84 |
Registrar of Zydus Lifesciences Buyback 2024
LINK INTIME INDIA PRIVATE LIMITED
C-101, 247 Park, 1st Floor, L.B.S. Marg,
Vikhroli West, Mumbai, 400 083, Maharashtra
Phone:Â +91 22 49186200
Email:Â [email protected]
Website:Â www.linkintime.com
Manager of Zydus Lifesciences Buyback 2024
ICICI SECURITIES LIMITED
ICICI Venture House, Appasaheb Marathe Marg,
Prabhadevi, Mumbai – 400 025, Maharashtra
Phone:Â +91 22 6807 7100
Email:Â [email protected] / [email protected]
Website:Â www.icicisecurities.com
Process to Participate in Zydus Lifesciences Buyback
All eligible shareholders of the company who own shares in the physical or demat form on the record date may participate in the buyback offer through their stockbroker. The eligible shareholders who hold the shares in demat form must notify their brokers of the details of the equity shares that they wish to tender in the buyback offer.
The shareholder must transfer the tendered shares to the clearing corporation’s Special account. In turn, the broker would place a buyback order on the stock exchange.
The eligible shareholders who own the shares in physical form must present their broker with the original share certificates and supporting documents. After document verification is complete, the broker places an order on the stock exchange and submits the original share certificate and TRS (Transaction Registration Slip) to the registrar.
Frequently Asked Questions
What are Zydus Lifesciences’ buyback dates?
Zydus Lifesciences’ share buyback opens in 29 February 2024 and closes in 6 March 2024.
Which type of buyback is Zydus Lifesciences buyback offer?
Zydus Lifesciences buyback is a tender offer.
What is Zydus Lifesciences buyback price?
Zydus Lifesciences buyback price is INR 1,005 per share.
What is Zydus Lifesciences buyback record date?
Zydus Lifesciences buyback record date is 23 February 2024.
How to participate in Zydus Lifesciences share buyback?
Zydus Lifesciences share buyback will be conducted through the tender process and investors who hold the shares on record date can place orders through their broker.
